ReviewClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2009
Hepatitis C in the elderly: epidemiology, natural history, and treatment.
Review in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 37 citations in OpenAlex.
- Safety and efficacy of directly-acting antiviral therapy for chronic hepatitis C virus in elderly people.Aging medicine (Milton (N.S.W)) · 2021Article
- High prevalence of occult hepatitis C infection in predialysis patients.World journal of hepatology · 2019Article
- Influential Factors of Successful Hepatitis C Treatment in Elderly Patients.Innovations in pharmacy · 2019Article
- Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis.Current infectious disease reports · 2016Article
- Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C.Clinical interventions in aging · 2016Article
- Liver physiology and liver diseases in the elderly.World journal of gastroenterology · 2013Review
- Hepatitis C virus and lichen planus: the real association.Hepatitis monthly · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Hepatitis C continues to be a major public health problem affecting approximately 3% of the global population. According to the World Health Organization, an estimated 170 million people have chronic hepatitis C. Ten percent to 20% of those who are chronically infected with hepatitis C will progress to cirrhosis and 5% will develop hepatocellular carcinoma. Although the safety and efficacy of hepatitis C therapies have been studied extensively in patients between the ages of 18 and 65, patients who are older than 65 still remain an understudied and difficult-to-treat population. This review discusses the epidemiology, natural history, and treatment of chronic hepatitis C in older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.